Dialysis Access Consortium (DAC)
The Dialysis Access Consortium (DAC) is an NIDDK-funded multi-center consortium that was developed to investigate interventions to improve hemodialysis vascular access outcomes in patients with end-stage renal disease (ESRD). The goals of the consortium are to identify effective therapies that will reduce the rate of graft and fistula failure in hemodialysis patients through a series of randomized, controlled, clinical trials over a five year period.
|GRAFT||Dialysis Access Consortium GRAFT|
|FISTULA||Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis|